- Dosing and - ENTYVIO® (vedolizumab) HCP Website
If PML is suspected, withhold dosing with ENTYVIO and refer to neurologist; if confirmed, discontinue ENTYVIO dosing permanently Liver Injury: There have been reports of elevations of transaminase and or bilirubin in patients receiving ENTYVIO ENTYVIO should be discontinued in patients with jaundice or other evidence of significant liver injury
|